CABIO Unveils Life-Stage Nutrition Innovations at Fi Europe 2025 in Paris
Introduction
At the 30th anniversary of Food Ingredients Europe in 2025, CABIO, a leading Chinese biotechnology company, made waves by presenting its extensive range of nutritional ingredients specifically designed for different life stages. This pivotal event also marked the official inauguration of CABIO's new global headquarters, the Synthetic Biology Innovation Center in Wuhan, setting the stage for the future of synthetic biology.
A New Horizon for CABIO
CABIO's cutting-edge headquarters symbolizes more than just state-of-the-art infrastructure; it reflects the company's ambitious vision and innovation capabilities in the field of synthetic biology. The new center embodies three fundamental values: deepening innovation through an open platform that invites brilliant minds to explore the limitless potential of synthetic biology, strengthening collaboration with dynamic spaces designed to fuel creativity and interdisciplinary partnerships, and amplifying impact with advanced facilities and enhanced R&D capacities to provide greater value to global partners and accelerate the sustainable growth of the industry.
Capturing Industry Trends
Recent insights from Innova Market Insights highlight that Human Milk Oligosaccharides (HMOs) are seeing an annual growth rate of 18% in life-stage nutrition applications, while the European Omega-3 market exhibits a robust compound annual growth rate (CAGR) of 7 to 9%. European consumers are increasingly prioritizing sustainable sourcing, scientific validation, and clean-label solutions. Health and well-being, along with gut health and personalized nutrition, emerge as key industry priorities—all of which align perfectly with CABIO's innovation strategy.
Five Key Product Lines
CABIO offers a comprehensive suite of products:
1. CABIO® ARA: Over 20 years of expertise in children's nutrition.
2. CABIO® Omega-3: Sourced from sustainable microalgae, addressing needs from children's brain development to adult cardiovascular health.
3. Keyshine® HMOs 2'-FL: Utilizing advanced fermentation for infant nutrition that imitates mother's milk, extending benefits into adult well-being.
4. Keyshine® N-Acetylneuraminic Acid: Delivers dual benefits for neurological development and skin health.
5. Along with diverse applications catering to customized collaborations across the full spectrum of both children's and adult nutrition.
A New Chapter in Global Collaboration
CABIO's new headquarters is not only a physical expansion but also serves as a catalyst for its global outreach. With advanced R&D facilities and an open innovation platform, CABIO continues to provide premium and traceable nutritional ingredients to partners in Europe and beyond, jointly propelling sustainable development within the nutrition and health sectors. Visitors at CABIO’s booth can explore the endless opportunities that nutritional innovation has to offer.
About CABIO
Founded in 2004, CABIO went public on the STAR Market of the Shanghai Stock Exchange in 2019 (stock code: 688089). The company’s foundation lies in synthetic biology as its core technology, supported by a technology platform encompassing key modules like strain-driven reproduction, precise cellular regulation, and efficient separation and purification. Through innovative cell factory preparation and sustainable bio-intelligent manufacturing methods, CABIO delivers high-quality functional ingredients, biological-derived products, and innovative solutions to global clients.
For more information, visit www.cabio.com.
Conclusion
CABIO’s presentation at Fi Europe 2025 signifies an important step forward in the food ingredients sector, showcasing their commitment to innovation and sustainability in life-stage nutrition. As they forge new partnerships and enhance global collaboration, CABIO is poised to lead the future of biotechnology in addressing nutritional needs across diverse life stages.
At the 30th anniversary of Food Ingredients Europe in 2025, CABIO, a leading Chinese biotechnology company, made waves by presenting its extensive range of nutritional ingredients specifically designed for different life stages. This pivotal event also marked the official inauguration of CABIO's new global headquarters, the Synthetic Biology Innovation Center in Wuhan, setting the stage for the future of synthetic biology.
A New Horizon for CABIO
CABIO's cutting-edge headquarters symbolizes more than just state-of-the-art infrastructure; it reflects the company's ambitious vision and innovation capabilities in the field of synthetic biology. The new center embodies three fundamental values: deepening innovation through an open platform that invites brilliant minds to explore the limitless potential of synthetic biology, strengthening collaboration with dynamic spaces designed to fuel creativity and interdisciplinary partnerships, and amplifying impact with advanced facilities and enhanced R&D capacities to provide greater value to global partners and accelerate the sustainable growth of the industry.
Capturing Industry Trends
Recent insights from Innova Market Insights highlight that Human Milk Oligosaccharides (HMOs) are seeing an annual growth rate of 18% in life-stage nutrition applications, while the European Omega-3 market exhibits a robust compound annual growth rate (CAGR) of 7 to 9%. European consumers are increasingly prioritizing sustainable sourcing, scientific validation, and clean-label solutions. Health and well-being, along with gut health and personalized nutrition, emerge as key industry priorities—all of which align perfectly with CABIO's innovation strategy.
Five Key Product Lines
CABIO offers a comprehensive suite of products:
1. CABIO® ARA: Over 20 years of expertise in children's nutrition.
2. CABIO® Omega-3: Sourced from sustainable microalgae, addressing needs from children's brain development to adult cardiovascular health.
3. Keyshine® HMOs 2'-FL: Utilizing advanced fermentation for infant nutrition that imitates mother's milk, extending benefits into adult well-being.
4. Keyshine® N-Acetylneuraminic Acid: Delivers dual benefits for neurological development and skin health.
5. Along with diverse applications catering to customized collaborations across the full spectrum of both children's and adult nutrition.
A New Chapter in Global Collaboration
CABIO's new headquarters is not only a physical expansion but also serves as a catalyst for its global outreach. With advanced R&D facilities and an open innovation platform, CABIO continues to provide premium and traceable nutritional ingredients to partners in Europe and beyond, jointly propelling sustainable development within the nutrition and health sectors. Visitors at CABIO’s booth can explore the endless opportunities that nutritional innovation has to offer.
About CABIO
Founded in 2004, CABIO went public on the STAR Market of the Shanghai Stock Exchange in 2019 (stock code: 688089). The company’s foundation lies in synthetic biology as its core technology, supported by a technology platform encompassing key modules like strain-driven reproduction, precise cellular regulation, and efficient separation and purification. Through innovative cell factory preparation and sustainable bio-intelligent manufacturing methods, CABIO delivers high-quality functional ingredients, biological-derived products, and innovative solutions to global clients.
For more information, visit www.cabio.com.
Conclusion
CABIO’s presentation at Fi Europe 2025 signifies an important step forward in the food ingredients sector, showcasing their commitment to innovation and sustainability in life-stage nutrition. As they forge new partnerships and enhance global collaboration, CABIO is poised to lead the future of biotechnology in addressing nutritional needs across diverse life stages.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.